Bennati, C., Paglialunga, L., Ricciuti, B., Metro, G., Marcomigni, L., Gili, A., & Crinò, L. (2016). Targeting EGFR and ALK in NSCLC: Current evidence and future perspective. Lung Cancer Manag.
Chicago Stili AlıntıBennati, Chiara, Luca Paglialunga, Biagio Ricciuti, Giulio Metro, Luca Marcomigni, Alessio Gili, ve Lucio Crinò. "Targeting EGFR and ALK in NSCLC: Current Evidence and Future Perspective." Lung Cancer Manag 2016.
MLA AlıntıBennati, Chiara, et al. "Targeting EGFR and ALK in NSCLC: Current Evidence and Future Perspective." Lung Cancer Manag 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..